Status:

COMPLETED

Risk Factors,PREvention and OutComes for CI-AKI in PatientS undErgoing PCI at Intensive Care Unit(PRECISE-ICU)

Lead Sponsor:

Kaiyang Lin

Conditions:

CIN

Eligibility:

All Genders

18+ years

Brief Summary

A retrospective, observational study included all consecutively critically ill patients undergoing percutaneous coronary intervention(PCI) at intensive care unit (ICU) in Fujian Provincial Hospital fr...

Eligibility Criteria

Inclusion

  • Critically ill patients undergoing PCI at ICU

Exclusion

  • pregnancy
  • lactation
  • end-stage renal disease (eGFR \<15 mL/min/1.73 m2)
  • long-term dialysis treatment
  • intravascular administration of contrast medium within the last 7 or 3 days postoperatively

Key Trial Info

Start Date :

January 1 2012

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2018

Estimated Enrollment :

755 Patients enrolled

Trial Details

Trial ID

NCT03791606

Start Date

January 1 2012

End Date

December 31 2018

Last Update

January 23 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fujian Provincial

Fuzhou, Fujian, China, 350001